2022年3月14日，歐盟食品安全局（EFSA）發(fā)布關(guān)于梨果、杏和桃中多效唑（paclobutrazol）的最大殘留限量審查后確認(rèn)數(shù)據(jù)的評(píng)估。
根據(jù)提交的新數(shù)據(jù)，對(duì)多效唑和三唑衍生物代謝物的風(fēng)險(xiǎn)評(píng)估進(jìn)行了更新，未顯示任何消費(fèi)者攝入問(wèn)題。部分原文報(bào)道如下：
The applicant Proplan Plant Protection Company submitted a request to the competent national authority in Austria (originally the United Kingdom) to evaluate the confirmatory data that were identified for paclobutrazol in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, two new metabolism studies performed on apples were submitted. In addition, two studies on the magnitude of residues in apples and pears providing data for triazole derivative metabolites were also submitted. The data gaps were considered satisfactorily addressed. The new information provided did not require a revision of the existing MRLs for pome fruits, apricots and peaches. An update of the risk assessment was performed for paclobutrazol and for the triazole derivative metabolites in light of the new data submitted and did not indicate any consumer intake concerns.
根據(jù)提交的新數(shù)據(jù)，對(duì)多效唑和三唑衍生物代謝物的風(fēng)險(xiǎn)評(píng)估進(jìn)行了更新，未顯示任何消費(fèi)者攝入問(wèn)題。部分原文報(bào)道如下：
The applicant Proplan Plant Protection Company submitted a request to the competent national authority in Austria (originally the United Kingdom) to evaluate the confirmatory data that were identified for paclobutrazol in the framework of the MRL review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, two new metabolism studies performed on apples were submitted. In addition, two studies on the magnitude of residues in apples and pears providing data for triazole derivative metabolites were also submitted. The data gaps were considered satisfactorily addressed. The new information provided did not require a revision of the existing MRLs for pome fruits, apricots and peaches. An update of the risk assessment was performed for paclobutrazol and for the triazole derivative metabolites in light of the new data submitted and did not indicate any consumer intake concerns.
